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We have used the Xenopus embryo as a test system for analyzing the activity of SpAN, a sea urchin metalloprotease in the
astacin family containing BMP1 and tolloid. Embryos expressing SpAN initiated gastrulation on a time scale indistinguish-
able from controls, but invagination of the vegetal pole was subsequently delayed by several hours. At tailbud stages the
most severely affected embryos were completely ventralized, lacking all dorsal structures. Molecular analysis of injected
embryos, using probes for both dorsal (xgsc and xnot) and ventral (xhox3 and xwnt8) mesoderm, indicates that SpAN
entralizes dorsal mesoderm during gastrula stages. These results mirror those previously obtained with BMP4, suggesting
hat SpAN may enhance the activity of this ventralizing factor. Consistent with this suggestion, we have shown that SpAN
locks the dorsalizing activity of noggin and chordin, two inhibitory binding proteins for BMP4, but not that of a
ominant-negative receptor for BMP4. In contrast, a dominant-negative SpAN, in which the metalloprotease domain has
een deleted, dorsalizes ventral mesoderm, a phenotype that can be rescued by coexpressing either SpAN or XBMP1. This
uggests that SpAN is mimicking a Xenopus metalloprotease responsible for regulating the activity of Xenopus BMPs during
astrulation. Moreover, our results raise the possibility that SpAN may function to facilitate BMP signaling in early sea
rchin embryos. © 1999 Academic Press
Key Words: SpAN; BMP1; tolloid; BMP4; sea urchin; Xenopus.
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1INTRODUCTION
Extracellular proteases are important regulators of a wide
variety of biological processes, including pattern formation
during embryonic development. In Drosophila, genetic
studies indicate that a metalloprotease called tolloid (Tld) is
required for proper patterning of dorsal embryonic struc-
tures during the cellular blastoderm stage, loss-of-function
tld mutations transforming dorsal cells toward more ven-
tral fates (Shimell et al., 1991; Arora and Nu¨sslein-Volhard,
1992; Ferguson and Anderson, 1992a). Recent studies have
shown that Tld degrades short gastrulation (Sog), an inhibi-
tory binding protein for the extracellular signaling molecule
decapentaplegic (Dpp) (Marque´s et al., 1997). Dpp plays a
ey role in specifying cell fates in the dorsal half of the
mbryo and appears to act in a graded fashion (Arora and
u¨sslein-Volhard, 1992; Ferguson and Anderson, 1992a;m
m
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All rights of reproduction in any form reserved.harton et al., 1993). High levels of Dpp specify the
mnioserosa, the most dorsal tissue type, while moderate
evels specify dorsal ectoderm and low levels allow the
evelopment of the ventral neurogenic ectoderm (Ferguson
nd Anderson, 1992b). Sog is expressed in ventrolateral cells
hat abut dorsal cells expressing both dpp and tld (Francois
t al., 1994). Genetic studies suggest that Sog diffuses into
he dorsal ectoderm to inhibit Dpp signaling (Zusman et al.,
988), suggesting a model in which the activity gradient of
pp is established through the opposing activities of Sog
nd Tld (Marque´s et al., 1997).
Tld is structurally related to the astacin family of metal-
oproteases (reviewed by Bond and Beynon, 1995) and in
articular to a subgroup of this family that includes bone
orphogenetic protein 1 (BMP1), mammalian Tld-like
mTll), zebrafish tolloid (zTld), and Xenopus xolloid (Xld)
Wozney et al., 1988; Takahara et al., 1996; Blader et al.,
997; Goodman et al., 1998). In addition to the N-terminal
etalloprotease domain, all of these proteases share ho-
ologous sequences in an extended C-terminal domain.
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64 Wardle et al.This C-terminal domain is typically composed of EGF and
CUB repeats, which are thought to be responsible for
protein–protein interactions (reviewed by Bork and Beck-
man, 1993). BMP1 is identical to procollagen C-proteinase,
an enzyme responsible for cleaving the C-terminal peptide
from fibrillar procollagens (Kessler et al., 1996; Li et al.,
1996), and a null mutation in the mouse bmp1 gene
disrupts the assembly of collagen fibers (Suzuki et al.,
1996). Although a function for mTll has yet to be described,
recent experiments have shown that zTld and Xld degrade
chordin, a vertebrate homologue of Sog (Blader et al., 1997;
Piccolo et al., 1997). This suggests a role for these proteases
in regulating cell signaling.
Dpp is a member of the transforming growth factor-b
superfamily that is most closely related to BMP2 and BMP4
(Padgett et al., 1987; Wozney et al., 1988). Indeed, human
MP4 can rescue flies mutant for dpp (Padgett et al., 1993),
and Dpp can induce ectopic bone formation in rodents
(Sampath et al., 1993). In Xenopus gastrulae, BMP4 appears
to act in a graded fashion to specify dorsoventral fates,
specifying ventral fates at high concentrations and lateral
fates at low concentrations (Dale et al., 1992; Dosch et al.,
1997; Wilson et al., 1997; Jones and Smith, 1998). Expres-
sion of bmp4 is gradually lost from dorsal regions of the
embryo during gastrula stages (Fainsod et al., 1994; Schmidt
et al., 1995; Hemmati-Brivanlou and Thomsen, 1995), and
blocking BMP4 signaling in ventral regions leads to the
differentiation of dorsal tissues such as muscle (Graff et al.,
1994; Suzuki et al., 1994; Schmidt et al., 1995). In contrast,
injection of bmp4 mRNA ventralizes dorsal mesoderm,
transforming dorsal tissues such as notochord and muscle
into ventral tissues such as blood and mesothelium (Dale et
al., 1992; Jones et al., 1992, 1996; Schmidt et al., 1995;
Dosch et al., 1997). Genetic evidence in favor of a role for
BMPs in dorsoventral patterning has been provided by the
recent finding that the zebrafish dorsalizing mutation swirl
disrupts a gene encoding a protein most closely related to
BMP2 (Kishimoto et al., 1997; Nguyen et al., 1998).
The gradient of BMP activity appears to be established by
the long-range effects of inhibitory binding proteins, such as
chordin and noggin, that are released by the dorsal meso-
derm (Smith and Harland, 1992; Smith et al., 1993; Sasai et
al., 1994; Piccolo et al., 1996; Zimmerman et al., 1996;
Dosch et al., 1997; Jones and Smith, 1998). Genetic studies
in zebrafish suggest that chordin has an important role to
play in dorsoventral patterning, since a null mutation in the
chordino gene, which encodes chordin, produces a moder-
ate ventralized phenotype (Hammerschmidt et al., 1996;
Schulte-Merker et al., 1997). This suggests a conserved
mechanism whereby an activity gradient of BMP(2/4)/Dpp
is maintained by the antagonistic activities of chordin/Sog
and Xld/Tld (De Robertis and Sasai, 1996; Ferguson, 1996).
Consistent with this, injection of ztld mRNA into zebrafish
embryos disrupts dorsoventral patterning in a way that is
remarkably similar to that of the chordino mutation (Blader
et al., 1997). Similarly, injection of either xld or bmp1
mRNAs into Xenopus embryos partially ventralizes dorsal
Copyright © 1999 by Academic Press. All rightmesoderm, giving rise to embryos with a reduced head and
cement gland and no notochord (Piccolo et al., 1997; Good-
man et al. 1998). In contrast, injection of mRNA encoding
a dominant-negative Xld resulted in a dorsalized phenotype
with an enlarged head and cement gland (Piccolo et al.,
1997).
In sea urchin embryos, a metalloprotease related to BMP1
and tolloid, has also been identified [SpAN (Strongylocen-
trotus purpuratus), Reynolds et al., 1992; or BP10 (Paracen-
trotus lividus), LePage et al., 1992). In S. purpuratus, span
mRNA is expressed in the animal three-quarters of the very
early blastula stage embryo, an area that gives rise to
ectoderm (Reynolds et al., 1992). It is also expressed to a
lesser and more variable extent in vegetal regions that
produce endoderm and secondary mesenchyme and is com-
pletely absent from the most vegetal regions of the embryo.
This pattern suggests that SpAN functions differentially
along the animal–vegetal axis. Moreover, the structural
homology between SpAN and Xld/Tld suggests that this
metalloprotease may regulate BMP activity in animal three-
quarters of the embryos. Since the phenotypes resulting
from injection of BMP mRNAs into Xenopus embryos are
well characterized, this system is ideal for exploring the
potential for SpAN to regulate BMP activity. Our results
show that injection of span mRNA ventralizes Xenopus
dorsal mesoderm in a dose-dependent manner: High doses
completely eliminate dorsal mesoderm from the embryo
and from animal caps exposed to the dorsal mesoderm-
inducing factor activin. The results also show that SpAN
ventralizes dorsal mesoderm during gastrula stages, consis-
tent with a role in regulating the activity of BMP4. That
this is, indeed, the case is suggested by our observations
that SpAN antagonizes the dorsalizing activity of chordin
and noggin, but not a dominant-negative receptor for BMP4.
In addition, we show that a dominant-negative SpAN
dorsalizes ventral mesoderm, consistent with inhibition of
BMP signaling. We conclude that SpAN has the ability to
regulate BMP4 in Xenopus embryos and may function
similarly in sea urchin embryos.
MATERIALS AND METHODS
Embryo Culture and Manipulation
Xenopus laevis embryos were injected at the one- to four-cell
stage with 10–16 nl of mRNA solution per blastomere in 0.13 MBS
13 MBS is 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 15 mM
epes, 0.3 mM CaNO3, 0.4 mM CaCl2, 0.8 mM MgSO4, 25mg/ml
gentamycin; adjusted to pH 7.6) containing 4% Ficoll (Sigma, Type
400). Injected embryos were scored using the dorsoanterior index
(DAI) of Kao and Elinson (1988). Animal caps were dissected from
mid-blastulae (stage 8) and cultured in 13 MBS either in the
presence or in the absence of 8 units/ml of human activin A (a kind
gift of Dr. J. C. Smith). Dorsal and ventral marginal zones were
dissected from early gastrulae (stage 10) and cultured in 13 MBS.
Histology was performed as described by Goodman et al. (1998).
s of reproduction in any form reserved.
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65SpAN Regulation of BMP4 ActivityIn Vitro Transcriptions
DNA templates for in vitro transcription were as follows. (A)
SP64T SpAN (Reynolds et al., 1992): A myc tag (EQKLISEEDLN-
top) was attached in frame to the carboxyl-terminal leucine of the
oding region of SpAN by PCR and the resulting construct was
lunt-end ligated into the BglII site of pSP64T. The 59 end of SpAN
equence included 90 nucleotides upstream of the translation
nitiation codon. (B) pSP64T DSpAN was constructed from pSP64T
pAN by converting glutamic acid 191 to alanine. Glutamic acid
91 is part of the highly conserved active site and is required for
atalytic activity (Bode et al., 1992). (C) pCS21 dominant-negative
SpAN (DNSpAN): PCR was used to introduce an EcoRI site at
nucleotides 1039–1044 of the span cDNA and 39 sequence ligated
to the EcoRI site at nucleotides 81–86 of Xenopus bmp1 (Goodman
et al., 1998). The resulting construct encodes a protein in which the
BMP1 signal sequence (amino acids 1–26) was fused to the
C-terminal domains of SpAN (amino acids 297–627), the proregion
and metalloprotease domain having been deleted. (D) pSP64T
Noggin: A 740-bp PCR fragment (nucleotides 220 to 720) contain-
ing the entire coding region of noggin (Smith and Harland, 1992)
was inserted into the BglII site of pSP64T. (This construct was a
kind gift of Dr. H. Isaacs). (E) pSP35 Chordin has been described by
Sasai et al. (1994). (F) pSP64T DxBMPR has been described by
Suzuki et al. (1995). (G) pSP64T XBMP4 has been described by Dale
et al. (1992). (H) pSP64T XBMP1 has been described by Goodman et
al. (1998). Capped synthetic mRNAs were transcribed with SP6
polymerase using an Ambion Megascript kit and taken up in sterile
RNase-free water at a final concentration of 100 ng/ml.
RNA Analysis
RNase protection assays were performed using the Ambion RPA
II kit according to the manufacturer’s instructions, except that
RNase digestion was carried out with 700 units/ml of RNase T1
alone. Samples were analyzed with antisense probes for a-actin,
aT4-globin, gsc, xnot, xwnt8, xhox3, and ornithine decarboxylase,
s previously described (Jones et al., 1996; Goodman et al., 1998).
otal RNA isolated from an equivalent amount of tissue was
ncluded for each sample. Control hybridizations with 10 mg of
RNA were always negative and are not shown in the figures.
hole mount in situ hybridizations were performed with DIG-
abeled antisense probes for xnot and xwnt8 as described by
oodman et al. (1998).
RESULTS
SpAN Ventralizes Dorsal Mesoderm
To test whether SpAN causes a phenotype in Xenopus
mbryos, 13 pg to 1.6 ng of span mRNA was injected at the
ne-cell stage and subsequent development observed. As
ontrols, embryos were injected with mRNA encoding
SpAN, in which the protease was inactivated by replacing
he catalytic glutamic acid (Glu191) with alanine. Embryos
njected with 1.6 ng span mRNA developed normally until
arly gastrula stages, forming a dorsal blastopore lip that
ater extended to the ventral side of the embryo on a time
cale indistinguishable from that of controls (Figs. 1A and
B). However, blastopore closure was subsequently delayed
y several hours in span injected embryos (Figs. 1C and 1D).
Copyright © 1999 by Academic Press. All rightThis effect was concentration dependent, blastopore clo-
sure being less delayed in embryos receiving lower doses of
span mRNA. Histological sections of the most delayed
embryos showed that, at stage 10.5, bottle cells had formed
on the dorsal side of both span mRNA-injected and sibling
control embryos but that, by stage 12, there was no ordered
migration of mesoderm on either the dorsal or the ventral
side of span mRNA-injected embryos (data not shown).
Injected embryos were allowed to develop to tailbud
stages (stages 28–30), when they were scored for dorsoante-
rior defects using the DAI scoring system of Kao and
Elinson (1988). In this classification, a score of 5 represents
a normal embryo and a score of 0 a fully ventralized
embryo. While embryos injected with 1.6 ng of Dspan
mRNA had an average DAI score of 5 (Fig. 1E and Table 1),
those injected with 1.6 ng of span had an average DAI score
of 0.11 (Fig. 1F and Table 1). Serial fivefold dilutions of
injected span mRNA resulted in the development of pro-
gressively more dorsoanterior structures (Table 1), such
that embryos injected with 13 pg of span RNA had an
average DAI score of 3.55. The effect of SpAN was depen-
dent on the site of expression, since injection of 64 pg of
FIG. 1. SpAN disrupts gastrulation and dorsoanterior develop-
ment. Injection of 1.6 ng of span mRNA at the one-cell stage does
ot disrupt the appearance of the dorsal blastopore lip (arrows) at
arly gastrula stages (B) when compared to embryos injected with
.6 ng of Dspan mRNA (A) or uninjected controls (not shown). At
ater stages during gastrulation, span mRNA-injected embryos (D)
xhibit a delay in blastopore closure (arrowheads) when compared
o controls (C). Note the greater size of the vegetal yolk plug in
pan mRNA-injected embryos. By tailbud stages span mRNA-
njected embryos exhibit no dorsoanterior structures (F).span mRNA into a single dorsal blastomere at the four-cell
stage gave an average DAI score of 2.53, while injection into
s of reproduction in any form reserved.
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66 Wardle et al.a single ventral blastomere gave an average DAI score of
4.43. Histological analysis confirmed that dorsal structures
such as neural tube, notochord, and somites failed to
differentiate in SpAN-expressing embryos (data not shown).
In addition, RNase protection assays showed that injection
of span mRNA resulted in a loss of a-actin expression, a
arker for muscle, and an increase in aT4-globin expres-
ion, a marker for ventral blood islands, although the latter
ncrease was quite small (Fig. 2A).
Ventralization of dorsal mesoderm by SpAN was also
emonstrated in animal caps treated with activin A, a
FIG. 2. SpAN ventralizes dorsal mesoderm. (A) Total RNA isolat
Dspan or span mRNA was analyzed by RNase protection using p
cytoskeletal actin (c-actin), or a combination of blood-specific aT4-g
results show a significant decrease in expression of a-actin mR
structures, and a small increase in the expression of aT4-globin. (B) A
or uninjected mid-blastulae (stage 8), which were then incubated
embryos had reached tailbud stage (stage 27). Total RNA was isolat
ABLE 1
oncentration-Dependent Ventralization of Xenopus Embryos by
span mRNA (pg) 0 1 2
0 0 0 0
13 6 15 16
64 24 13 17
320 74 23 26
1600 119 15 0
Note. Embryos were injected at the one-cell stage with the ind
orsoanterior index (DAI) of Kao and Elinson (1988): a score of 5
icrocephalic, 1 5 acephalic, and 0 5 fully ventralized. Numbers i
njection of 1600 pg of Dspan mRNA gave a mean DAI of 5.0 (N 5and aT4-globin. The results show that SpAN ventralizes the mesoderm
and increasing expression of aT4-globin.
Copyright © 1999 by Academic Press. All rightorsal mesoderm-inducing factor. Animal caps were iso-
ated from blastulae injected with either 1.6 ng of span or
Dspan mRNA, or from uninjected embryos, and incubated
in medium containing activin A until sibling control em-
bryos had reached stages 26–27. In the presence of activin
A, control caps elongated and expressed the muscle marker
a-actin (Fig. 2B, lanes 2 and 4), while span-injected animal
caps did not elongate and expressed the blood marker
aT4-globin (Fig. 2B, lane 6). These results demonstrate that
pAN both blocks dorsal morphogenetic movements and
entralizes dorsal mesoderm.
m uninjected embryos and embryos injected with 1.6 ng of either
s for either muscle-specific a-actin (m-actin), which also detects
and the uniformly expressed ornithine decarboxylase (ODC). The
in span mRNA-injected embryos, confirming the loss of dorsal
al caps were isolated from injected (1.6 ng of Dspan or span mRNA)
he presence (1) or absence (2) of human activin A until control
d analyzed by RNase protection using probes for a-actin (m-actin)
ted span
DAI score
3 4 5 Mean
0 6 112 4.95
7 39 49 3.55
18 35 16 2.61
8 24 2 1.33
0 0 0 0.11
d amount of span mRNA and scored at stages 28–30 using the
rmal embryo, 4 5 reduced eyes and forehead, 3 5 cyclopic, 2 5
te the number of cases at each DAI score. In the same experimented fro
robe
lobin
NA
nim
in t
ed anInjec
icate
5 noin activin-treated caps, lowering the expression of muscle a-actin
s of reproduction in any form reserved.
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67SpAN Regulation of BMP4 ActivityVentralization Occurs during Gastrula Stages
The phenotype of span mRNA-injected embryos re-
sembles that of embryos injected with bmp4 mRNA; in
both cases a dorsal blastopore lip forms at the beginning of
gastrulation, but blastopore closure is subsequently delayed
and dorsal structures do not develop (Dale et al., 1992; Jones
et al., 1992). In embryos injected with bmp4 mRNA dorsal
genes such as goosecoid and xnot are activated as normal at
the start of gastrulation, but expression is soon down-
regulated (Jones et al., 1996). To determine if SpAN has a
similar effect, we injected embryos with 1.6 ng of span or
Dspan mRNA and analyzed the expression of both dorsal
and ventral mesodermal markers at selected stages during
gastrulation, both by RNase protection (Fig. 3A) and by
whole mount in situ hybridization (Figs. 3B–3E). Tran-
scripts for goosecoid and xnot were expressed at normal
levels in dorsal marginal zone explants from span mRNA-
injected early gastrulae (Fig. 3A, compare lanes 1 and 4), but
accumulated to significantly lower levels in those from late
gastrulae (Fig. 3A, compare lanes 2 and 5) or early neurulae
(Fig. 3A, compare lanes 3 and 6). In contrast, expression of
xhox3 and xwnt8, two markers for ventral mesoderm, was
very low in the DMZ of span mRNA-injected early gastru-
lae (Fig. 3A, lanes 1 and 4), but strongly up-regulated in late
gastrulae (Fig. 3A, lanes 2 and 5) and early neurulae (Fig. 3A,
FIG. 3. SpAN ventralizes dorsal mesoderm during gastrulation. D
mRNA-injected (1.6 ng/embryo) early gastrulae, incubated until
expression of both dorsal- and ventral-specific genes by RNase p
determined as a loading control. The dorsal-specific genes goosecoid
xpression is subsequently down-regulated. In contrast, expressio
mRNA-injected embryos as gastrulation progresses. Gastrulae we
ount in situ hybridization. In control stage 12 embryos, xnot was
diffuse in span mRNA-injected embryos (C), consistent with the lo
lateral mesoderm, but not dorsal mesoderm, of control stage 12 em
mRNA-injected embryos (E), demonstrating that ventralization oflanes 3 and 6) compared to controls.
These results were confirmed by whole mount in situ
Copyright © 1999 by Academic Press. All righthybridization using probes for xnot and xwnt8. In normal
embryos, xnot transcripts accumulate throughout the mar-
ginal zone, with higher levels on the dorsal side (data not
shown); the message is then progressively restricted to the
future notochord by the end of gastrulation (stage 12, Fig. 3B;
see also von Dassow et al., 1993). In SpAN-expressing em-
bryos, xnot staining also is observed throughout the marginal
zone at the start of gastrulation (data not shown), but the
signal is more diffuse and by stage 12 is not detectably
concentrated in dorsal regions (Fig. 3C). Alteration of cell fates
in the DMZ of mid- to late gastrulae is also suggested by the
fact that xwnt8, a ventral marker, expands into this region in
embryos injected with span mRNA (Fig. 3, compare D with E).
Our results show that span mRNA-injected embryos are
indistinguishable from their sibling controls at early gas-
trula stages, but that dorsal-specific genes are subsequently
down-regulated, and ventral-specific genes are up-regulated,
on the dorsal side of mid- to late gastrulae. We conclude
that dorsal mesoderm is converted to ventral mesoderm in
span mRNA-injected embryos and that this occurs during
gastrulation.
SpAN Suppresses Dorsalization by Noggin and
Chordin, but Not by a Dominant-Negative BMP
Receptor
marginal zones (DMZs) were isolated from both control and span
rol embryos reached the indicated stages, and analyzed for the
tion (A). Levels of ornithine decarboxylase (ODC) mRNA were
) and xnot are initially induced in span mRNA-injected DMZs, but
the ventral-specific genes xhox3 and xwnt8 is increased in span
o analyzed for xnot (B, C) and xwnt8 (D, E) expression by whole
rly localized to the dorsal blastopore lip (B) but was absent or very
dorsal structures. In contrast, xwnt8 was expressed in ventral and
s (D), but expression expanded into the dorsal mesoderm of span
orsal marginal zone has occurred by this stage.orsal
cont
rotec
(gsc
n of
re als
clea
ss ofOne explanation for our results is that SpAN is activating
BMP signaling, and to test this we coinjected mRNAs for
s of reproduction in any form reserved.
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68 Wardle et al.SpAN and a dominant-negative receptor (DxBMPR) for
BMP2/4 that blocks intracellular signaling by endogenous
receptors (Graff et al., 1994; Suzuki et al., 1994, 1995). 500
pg of Dxbmpr mRNA was injected into both blastomeres at
the two-cell stage, either alone or in combination with 75
pg of span mRNA, and the ventral marginal zone (VMZ)
isolated at early gastrula stages. VMZs were then cultured
until sibling embryos had reached tailbud stages (stages
26–27) and analyzed for expression of a-actin and aT4-
globin mRNAs by RNase protection assays (Fig. 4). Injec-
tion of Dxbmpr alone induced a significant increase in
a-actin expression, and a concomitant decrease in aT4-
lobin expression, when compared to controls (Fig. 4, lanes
and 7). Coinjection of span mRNA, at levels sufficient to
arkedly ventralize Xenopus embryos (see Table 1), had no
ffect on expression of either a-actin or aT4-globin mRNAs
in Dxbmpr-injected VMZs, indicating that a functional
BMP2/4 signaling pathway is required for the ventralizing
activity of SpAN.
We also coexpressed SpAN with chordin or noggin, two
extracellular proteins that directly bind and inactivate
BMP2 and BMP4. As a consequence, these proteins dorsal-
ize ventral mesoderm when expressed in ventral sectors of
the marginal zone during early stages of Xenopus develop-
FIG. 4. SpAN blocks the dorsalizing activity of chordin and
noggin. Embryos were injected with the indicated mRNAs (see text
for amounts) and VMZs were cut from early gastrulae. These were
cultured until sibling control embryos had reached stage 27 and
then analyzed for expression of muscle-specific a-actin (m-actin)
nd blood-specific aT4-globin. Levels of cytoskeletal actin (c-actin)
were determined as a loading control for muscle actin, and ODC
as determined as a loading control for aT4-globin. chordin (lane
), noggin (lane 5), and a dominant-negative BMP receptor
DxBMPR; lane 7) dorsalize ventral mesoderm as shown by the high
evels of a-actin expression and lower levels of aT4-globin expres-
ion when compared to control VMZs (lane 1). SpAN was not able
o ventralize dorsal mesoderm induced by DxBMPR(lane 8) indicat-
ng that SpAN acts upstream of the BMP receptor and requires a
unctional BMP signaling pathway to act. SpAN, however, is able
o overcome the dorsalizing activity of both chordin (lane 4) and
oggin (lane 6).ment (Fig. 4, lanes 3 and 5). A quantity of 75 pg of span
mRNA was injected into both blastomeres at the two-cell
e
V
Copyright © 1999 by Academic Press. All rightstage, with either 25 pg of noggin or 500 pg of chordin
mRNA. These amounts of noggin and chordin mRNAs
were chosen because they induced similar levels of a-actin
xpression, in isolated VMZs, as the concentration of
xbmpr mRNA described above (Fig. 4, lanes 3, 5, and 7).
oinjected VMZs expressed very little a-actin mRNA and
had increased expression of aT4-globin mRNA (Fig. 4, lanes
and 6), demonstrating that SpAN can counteract the
orsalizing activity of both chordin and noggin. These
esults provide further evidence that SpAN ventralizes
enopus embryos by activating BMP signaling.
Dominant-Negative SpAN Dorsalizes Ventral
Mesoderm
To further characterize the role of SpAN in BMP signal-
ing, we have made a construct (DNSpAN) in which the
N-terminal proregion and metalloprotease domain of SpAN
are deleted (Fig. 5A). The C-terminal half of SpAN, consist-
ing of a single EGF domain, two CUB domains, and a
threonine-rich domain (Reynolds et al., 1992), was fused to
the signal sequence of Xenopus BMP1, to direct it to the
secretory pathway. Since the C-terminal half of the protein
is thought to be responsible for protein–protein interac-
tions, we anticipated that it would compete with wild-type
SpAN for its substrates and thereby act as a dominant-
negative mutation. To test this we coinjected 150 pg of span
and 1.5 ng of dnspan mRNAs at the two-cell stage and
incubated animal caps in the dorsal mesoderm inducing
factor activin A. Injection of 150 pg of span mRNA alone
blocked the elongation of activin-treated animal caps, an
activity that was in turn substantially blocked by coinjec-
tion of an excess of dnspan (data not shown). Moreover,
RNase protection assays showed that dnspan blocked the
ability of coinjected span to suppress a-actin expression in
these animal caps (Fig. 5B), thus confirming that DNSpAN
acts as a dominant negative.
If SpAN were activating BMPs by mimicking an endoge-
nous protease such as BMP1 or Xld, we would anticipate
that DNSpAN would dorsalize ventral mesoderm. Injection
of up to 3 ng of dnspan mRNA has little effect on subse-
quent development, the only phenotypic effect being an
enlarged cement gland in up to 10% of injected embryos at
early tailbud stages (data not shown). We therefore isolated
VMZs from early gastrulae injected with 1.5 ng of dnspan
mRNA and incubated them until tailbud stages. Histolog-
ical analysis demonstrated that dnspan-injected VMZs
were dorsalized, differentiating muscle (20/20 cases), noto-
chord (1/20), and neural tissue (2/20) (Figs. 5C–5D). This
was confirmed by RNase protection assays using probes for
a-actin and aT4-globin, DNSpAN increasing the expression
f a-actin and decreasing that of aT4-globin (Fig. 5E).
inally, we showed that the dorsalizing activity of DN-
pAN could be blocked by coexpressing SpAN or XBMP1. A
uantity of 750 pg of dnspan mRNA was coinjected with
ither 75 pg of span or 750 pg of Xenopus bmp1 mRNA, and
MZs were isolated from early gastrulae. At tailbud stages
s of reproduction in any form reserved.
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69SpAN Regulation of BMP4 Activitythey were analyzed for a-actin expression by RNase protec-
ion assays (Fig. 5F). Coinjected VMZs expressed very little
a-actin mRNA (Fig. 5F, lanes 3 and 4), in contrast to VMZs
injected with dnspan mRNA alone (Fig. 5F, lane 2). This
uggests that DNSpAN acts as a dominant inhibitor of
FIG. 5. DNSpAN dorsalizes ventral mesoderm. (A) Schematic
diagram illustrating the structure of SpAN (top) and DNSpAN
(bottom). The C-terminal EGF- (E), CUB- (C), and threonine-rich (T)
domains of SpAN were fused to the signal sequence (S) of XBMP1,
thereby deleting the proregion (P) and metalloprotease (MP) do-
mains. (B) Injection of 1.5 ng of dnspan mRNA blocks the ventral-
izing activity of 150 pg of coinjected span mRNA in activin-treated
animal caps. Embryos were injected at the two-cell stage and
incubated until stage 27 when they were analyzed by RNase
protections using a probe for a-actin. Levels of cytoskeletal actin
(c-actin) were determined as a loading control. (C, D) VMZs
isolated at stage 10 and incubated until stage 40, whereas controls
differentiate ventral-type mesoderm (C), DNSpAN injected VMZs
(D) differentiate muscle (mu) and neural tissue (nt). (E) RNase
protection analysis using probes for muscle-specific a-actin (m-
ctin) and blood-specific aT4-globin demonstrates that DNSpAN
xpressing VMZs are dorsalized. (F) RNase protection analysis on
solated VMZs using a probe for a-actin (m-actin), demonstrating
that coexpressed SpAN or XBMP1 block the dorsalizing activity of
DNSpAN.ndogenous proteases that are responsible for regulating
MP activity during early Xenopus development.
Copyright © 1999 by Academic Press. All rightDISCUSSION
SpAN Activates BMP Signaling
We have used the Xenopus embryo as an assay to test
whether the sea urchin metalloprotease SpAN can act as an
extracellular regulator of BMP signaling. The effects of
modulating the BMP4 signaling pathway in early Xenopus
embryos have been extensively studied (reviewed by Thom-
sen, 1997; Graff, 1997), making this an ideal system for
testing the activity of SpAN. Our results show that the
phenotype of span-injected embryos is remarkably similar
to that of bmp4-injected embryos (e.g., see Dale et al., 1992;
Jones et al., 1992; Dosch et al., 1997). First, SpAN progres-
sively ventralizes Xenopus embryos in a concentration-
dependent manner, injected embryos first losing anterior
structures such as the head and then the notochord, neural
tube, and somites. A concomitant increase in the ventral
blood islands indicates a transformation from dorsal to
ventral cell fates. Second, SpAN does not block the forma-
tion of the dorsal blastopore lip in early gastrulae, but
invagination of the vegetal yolk mass is subsequently
delayed. This is reflected at the molecular level because the
dorsal blastopore lip markers goosecoid and xnot are ex-
pressed at normal levels in span-injected early gastrulae,
but are rapidly down-regulated as gastrulation proceeds. At
the same time, expression of two ventral genes, xwnt8 and
xhox3, expands into the dorsal marginal zone. Third, SpAN
ventralizes dorsal mesoderm in animal caps incubated in
activin, a potent inducer of dorsal mesoderm in this system,
and blocks morphogenetic movements seen in activin-
treated control caps. Fourth, we have shown that SpAN
does not block the dorsalizing activity of a truncated
receptor for BMP2/4. This receptor blocks signaling through
endogenous receptors and transforms ventral into dorsal
mesoderm (Graff et al., 1994; Suzuki et al., 1994, 1995). The
failure of SpAN to block this dorsalization demonstrates
that a functional BMP receptor is required for its ventraliz-
ing activity. In contrast, SpAN does block the dorsalizing
activity of coexpressed chordin or noggin, two inhibitory
binding proteins for BMP2/4. Finally, dominant-negative
SpAN, in which the N-terminal proregion and metallopro-
tease domain have been deleted, dorsalizes ventral meso-
derm, a phenotype characteristic of inhibitors of BMP
signaling (reviewed by Thomsen, 1997; Graff, 1997).
The simplest interpretation of these results is that SpAN
activates endogenous Xenopus BMPs, which are then avail-
able to activate their receptors. Recent studies have shown
that Drosophila Tld, zebrafish Tld, and Xenopus Xld, are
able to activate Dpp and BMP4 by proteolytically releasing
them from the inhibitory binding proteins Sog and chordin
(Blader et al., 1997; Marque´s et al., 1997; Piccolo et al.,
1997). Since SpAN can block the dorsalizing activity of both
chordin and noggin in a VMZ assay, one possibility is that
SpAN may also proteolytically release BMPs from these
inhibitory binding proteins. However, experiments in
which conditioned media from SpAN-injected Xenopus
s of reproduction in any form reserved.
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70 Wardle et al.oocytes were combined with chordin or noggin in vitro
ailed to demonstrate any degradation of these proteins by
pAN (Wardle and Dale, unpublished). One explanation for
his result is that SpAN only degrades chordin or noggin
rebound with BMPs, as shown for the degradation of Sog
y Tld (Marque´s et al., 1997). Alternatively, SpAN could
release BMPs from other sources, including inhibitory bind-
ing proteins such as follistatin, cerberus, gremlin, and DAN
(Fainsod et al., 1997; Hsu et al., 1998), as well as compo-
nents of the extracellular matrix, such as heparin and type
IV collagen (Wozney et al., 1988; Paralkar et al., 1990;
Vukicevic et al., 1994). We have evidence that SpAN may
affect the ECM since fibronectin levels are reduced in
SpAN-injected embryos. The amounts of chordin and nog-
gin used in the VMZ assay may be insufficient to fully
inhibit the increased levels of active BMPs released from
these sources by SpAN.
SpAN Mimics Xenopus Proteases
The ventralizing activity of SpAN is similar to that of
XBMP1 and Xld, two metalloproteases closely related to
SpAN (Goodman et al., 1998), suggesting that SpAN may be
mimicking these proteases. Consistent with this DNSpAN
dorsalizes ventral mesoderm in the VMZ assay, an activity
that can be overcome by coinjecting mRNA for XBMP1.
Similar results have been obtained for dominant-negative
XBMP1 and Xld (Wardle et al., manuscript in preparation),
indicating that DNSpAN may inhibit these proteases. How-
ever, SpAN is much more active than either XBMP1 or Xld;
in our previous study (Goodman et al., 1998) 3 ng of injected
xbmp1 and xld mRNA gave mean DAI scores of 3.84 and
.68, respectively, while in this study we obtained a similar
ean DAI score, 3.55, from only 13 pg of injected span
RNA. A partial explanation for the difference in activity
etween SpAN and XBMP1/Xld is that we routinely find
hat span mRNA translates more efficiently than either
bmp1 or xld mRNA, in both cell-free extracts and injected
enopus oocytes, although this difference (2- to 3-fold) is
ot sufficient to account for the large differences in ventral-
zing activity that we observe. An additional explanation is
hat much more of SpAN is converted into active protease
han either XBMP1 or Xld. We have no evidence to support
his explanation, but structural studies indicate that the
-terminal proregion must be proteolytically removed be-
ore members of the astacin family can become active (Bode
t al., 1992). Consistent with this, deleting the proregion
rom Drosophila Tld generates an enzyme that is 10- to
0-fold more active than the wild-type protease (Marque´s et
l., 1997). It is possible that the activity of XBMP1 and Xld,
ut not SpAN, is restrained by continuing interactions with
he proregion, as is the case for other metalloproteases (Van
art and Birkedal-Hansen, 1990). In line with this sugges-
ion there is no discernible homology between the prore-
ion of SpAN and the proregion of either XBMP1 or Xld,
hile the latter two proteins contain a conserved 21 amino
cid sequence in the proregion (Goodman et al., 1998). The
Copyright © 1999 by Academic Press. All rightunction of this conserved sequence, which is also present
n mammalian BMP1, mTll, Drosophila Tld related, Aply-
ia BMP1/Tld, and sea urchin BMP1 (Goodman et al., 1998),
s at present unknown, but it may be responsible for
egulating the activity of the adjoining metalloprotease.
inally, SpAN, but not BMP1 and Xld, could act in both
MP and non-BMP pathways, each of which contributes to
he ventralized phenotype.
A Conserved System of Dorsoventral Patterning?
It has recently become clear that a conserved molecular
pathway is utilized by both vertebrates and insects to
regulate dorsoventral patterning at the earliest stages of
development (reviewed by De Robertis and Sasai, 1996;
Ferguson, 1996). In this pathway the active signaling mol-
ecule, BMP4/Dpp, is regulated by the opposing activities of
inhibitory binding proteins, chordin/Sog, and metallopro-
teases, Xld/Tld. The role of Xld/Tld in this pathway is to
regulate the release of active BMP4/Dpp from inactive
complexes with chordin/Sog (Blader et al., 1997; Marque´s et
al., 1997; Piccolo et al., 1997). Considering the large evolu-
tionary divergence between vertebrates and insects, it is
highly likely that this pathway is also used by other animal
groups, including echinoderms. Sea urchin embryos express
a structural and functional homologue of vertebrate BMP4,
and injection of bmp4 mRNA converts vegetal cells to more
animal fates (Angerer et al., manuscript in preparation).
Moreover, injection of span mRNA into sea urchin embryos
causes specific phenotypes that are similar to those ob-
tained with injected bmp4 mRNA. In contrast, injection of
noggin mRNA causes the opposite vegetalized phenotypes.
Taken together, these results suggest that a sea urchin BMP
plays a role in patterning the animal–vegetal axis during
embryogenesis and that SpAN may be involved in regulat-
ing the activity of this signaling molecule.
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